The DCAT Global Summit 2026

Bio/pharma companies and their suppliers are facing key challenges and opportunities as digital transformation, including artificial intelligence (AI), emerging technologies, and ever-changing global supply lines reshape the bio/pharmaceutical value chain.

The DCAT Global Summit 2026: The Future of Bio/Pharma: Mastering the Supply Chain, Digitalization & Global Shifts, which will be held 10-ll June 2026, in Barcelona, Sitges will bring together industry and thought leaders to share practical insights and first-hand experience into how to adapt now and be future-ready to these competitive forces. The Summit will explore the current and future use of AI and other digital technologies in accelerating timelines in R&D, improving manufacturing, and enhancing supply-chain performance and how the rising digital bar will impact the way business is done between bio/pharma companies and their suppliers, including in reskilling for digitalization. The Summit will also examine what is top-of-mind for the industry: strengthening supply-chain resilience amid geopolitical and trade uncertainty, strategies for de-risking supply chains, and the financial and market impact of shifting global supply lines.

Stay tuned to the DCAT Weekly and your inbox for upcoming details on the 2026 DCAT Global Summit, including how to apply to present and register to attend.


2025 DCAT Summit Recap


“PCI has been very pleased with DCAT’s strategic approach in broadening to the European based Summit event.  The program, the topics and the global supply chain perspective fosters a great environment for rich dialogue, evaluating trends and market innovations, as well as evaluating evolving patient needs both in established and emerging markets.  It is a very collaborative and effective event that we are excited to help foster and grow for the benefit of patient focused outcomes.  We highly endorse it!”

Justin Schroeder, Global Vice President – Technical Sales, PCI Pharma Services

“The DCAT Summit was one of the most impactful conferences I have attended.  The combination of education, networking, and the open sharing of opinions, left me feeling incredibly upbeat about the future of the pharmaceutical industry.”

Jim Fries, Chief Executive Officer, Rx-360

“The DCAT Summit in Lugano was unlike any other—an inspiring convergence of visionary speakers, fresh perspectives, and meaningful dialogue. The breadth of presentations opened my mind to new possibilities, and the opportunity to connect with senior leaders left me energized and motivated to shape the future of our industry.”

Stacey R. Vaughan, Vice President, Marketing & Portfolio Management Elastomers & Primary Containment, West Pharmaceutical Services, Inc.